Tilray Brands (TLRY) Cost of Revenue (2017 - 2026)
Tilray Brands' (TLRY) quarterly Cost of Revenue came in at $191.2 million in Q2 2026, up 21.86% YoY from $156.9 million in Q2 2025, and up 25.97% on a QoQ basis from $151.8 million in Q1 2026.
Tilray Brands (TLRY) Cost of Revenue (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Cost of Revenue data on file, last reported at $191.2 million in Q2 2026.
- Quarterly Cost of Revenue rose 21.86% year-over-year to $191.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $655.0 million (up 12.79% YoY) and the FY2026 annual result came in at $655.0 million, up 12.79% from the prior year.
- Cost of Revenue grew to $191.2 million in Q2 2026, from $151.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $191.2 million in Q2 2026 to a low of $101.3 million in Q4 2022.
- A 5-year average of $141.9 million and a median of $146.9 million in 2023 frame the typical range for Cost of Revenue.
- The widest YoY moves for Cost of Revenue: up 44.55% in 2023, down 26.89% in 2023.
- Tracing TLRY's Cost of Revenue over 5 years: stood at $101.3 million in 2022, then jumped by 44.55% to $146.4 million in 2023, then advanced by 2.3% to $149.7 million in 2024, then grew by 6.87% to $160.0 million in 2025, then increased by 19.49% to $191.2 million in 2026.
- The last three Cost of Revenue figures came in at $191.2 million (Q2 2026), $151.8 million (Q1 2026), and $160.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Tilray Brands | 509.96 Mn | 275.32 Mn | 90.52 Mn | 191.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 191.19 Mn |
| May 31, 2026 | 191.19 Mn |
| Feb 28, 2026 | 151.78 Mn |
| Feb 28, 2026 | 151.78 Mn |
| Nov 30, 2025 | 160.01 Mn |
| Nov 30, 2025 | 160.01 Mn |
| Aug 31, 2025 | 152.03 Mn |
| Aug 31, 2025 | 152.03 Mn |
| May 31, 2025 | 156.90 Mn |
| May 31, 2025 | 156.90 Mn |
| Feb 28, 2025 | 133.77 Mn |
| Feb 28, 2025 | 133.77 Mn |
| Nov 30, 2024 | 149.73 Mn |
| Nov 30, 2024 | 149.73 Mn |
| Aug 31, 2024 | 140.34 Mn |
| Aug 31, 2024 | 140.34 Mn |
| May 31, 2024 | 147.53 Mn |
| May 31, 2024 | 147.53 Mn |
| Feb 29, 2024 | 138.94 Mn |
| Feb 29, 2024 | 138.94 Mn |